Incidence and Associated Factors of Abnormal Uterine Bleeding During Menstruation in Chinese Women of Childbearing Age Receiving Various Oral Antithrombotic Regimens After Cardiovascular Surgery: A Prospective Longitudinal Observational Study
This study aims to investigate uterine bleeding during menstruation in women taking antithrombotic medications after cardiac surgery. It will evaluate the proportion of patients with abnormal bleeding, such as heavy menstrual bleeding and prolonged menstrual periods, identify associated risk factors, and determine the characteristics of high-risk female patients.
• Female patients aged 18 to 49 years.
• Underwent cardiovascular surgery at our institution (e.g., coronary artery bypass grafting, heart valve repair/replacement, aortic surgery, congenital heart disease correction, heart transplantation).
• Absence of heavy menstrual bleeding (HMB) or prolonged menstrual bleeding (\> 8 days) during the two consecutive menstrual cycles immediately prior to surgery.
• Experienced at least one complete menstrual bleeding episode within the predefined postoperative follow-up window.
• Receiving postoperative oral antiplatelet therapy (e.g., aspirin, clopidogrel) and/or oral anticoagulant therapy (e.g., rivaroxaban, warfarin).
• Concurrent use or non-use of estrogen/progestin modulation therapy is permitted.